GH

Guardant Health Inc

Apr 02 • 04:00PM ET

93.83

+2.68 2.94 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN QGEN EXAS FLGT BIO SRPT MYGN NTRA CDNA TXG

| Held by: VTI IWM VB VBK VXF IWO SCHA VTWO ARKG CGGR

Index	RUT	P/E	-	EPS (ttm)	-3.31	Insider Own	3.80%	Shs Outstand	130.64M	Perf Week	6.50%
Market Cap	12.31B	Forward P/E	-	EPS next Y	-1.93	Insider Trans	-8.98%	Shs Float	126.19M	Perf Month	0.87%
Enterprise Value	12.82B	PEG	-	EPS next Q	-0.81	Inst Own	100.79%	Short Float	9.08%	Perf Quarter	-8.14%
Income	-416.28M	P/S	12.53	EPS this Y	11.04%	Inst Trans	6.02%	Short Ratio	5.68	Perf Half Y	49.77%
Sales	982.02M	P/B	-	EPS next Y	34.53%	ROA	-23.79%	Short Interest	11.45M	Perf YTD	-8.14%
Book/sh	-0.76	P/C	10.24	EPS next 5Y	65.70%	ROE	-	52W High	120.74 -22.29%	Perf Year	115.75%
Cash/sh	9.16	P/FCF	-	EPS past 3/5Y	19.67% -4.99%	ROIC	-26.29%	52W Low	36.36 158.06%	Perf 3Y	300.30%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	29.75% 27.92%	Gross Margin	64.46%	Volatility	5.97% 4.83%	Perf 5Y	-40.23%
Dividend TTM	-	EV/Sales	13.05	EPS Y/Y TTM	6.77%	Oper. Margin	-44.47%	ATR (14)	4.92	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.56	Sales Y/Y TTM	32.88%	Profit Margin	-42.39%	RSI (14)	54.72	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	4.84	EPS Q/Q	-11.34%	SMA20	6.67%	Beta	1.67	Target Price	130.64
Payout	-	Debt/Eq	-	Sales Q/Q	39.37%	SMA50	-4.00%	Rel Volume	0.87	Prev Close	91.15
Employees	2506	LT Debt/Eq	-	Earnings	Feb 19 AMC	SMA200	17.53%	Avg Volume	2.02M	Price	93.83
IPO	Oct 04, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-30.41% 3.25%	Trades		Volume	1,743,890	Change	2.94%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-20-26	Reiterated	Canaccord Genuity	Buy	$125 → $135
Feb-17-26	Initiated	Robert W. Baird	Outperform	$120
Jan-05-26	Downgrade	Evercore ISI	Outperform → In-line	$105
Dec-02-25	Resumed	Morgan Stanley	Overweight	$130
Sep-25-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$75
Sep-22-25	Resumed	Wells Fargo	Overweight	$72
Apr-10-25	Initiated	Mizuho	Outperform	$55
Jan-23-25	Initiated	Barclays	Overweight	$60
Jun-28-24	Upgrade	Guggenheim	Neutral → Buy	$36
Jun-03-24	Resumed	Jefferies	Buy	$32
Apr-24-24	Resumed	Craig Hallum	Buy	$28
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-13-23	Upgrade	Raymond James	Mkt Perform → Outperform	$27
Sep-28-23	Initiated	Bernstein	Outperform	$34
Sep-27-23	Upgrade	Piper Sandler	Neutral → Overweight	$40
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-26-23	Upgrade	Citigroup	Neutral → Buy	$28 → $40
May-05-23	Initiated	UBS	Buy	$40
Mar-09-23	Downgrade	Citigroup	Buy → Neutral	$60 → $33

Show Previous Ratings

Mar-30-26 08:05AM	Guardant Health's InfinityAI Real-World Evidence Supports Approval of ENHERTU for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan (Business Wire)
08:00AM	Gamehost Enters into Definitive Agreement to Be Acquired by Pure Casino Entertainment for $13.65 per Share (TMX Newsfile)
Mar-24-26 09:15AM	Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data (PR Newswire)
Mar-18-26 08:53PM	Gamehost to Correct Administrative Expense Allocation in Financial Statements; No Impact on Operations or Cash Flow (TMX Newsfile)
08:05AM	Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026 (Business Wire)
08:05AM	Loading…
Mar-16-26 08:05AM	Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership (Business Wire)
Mar-13-26 08:05AM	New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare (Business Wire)
Mar-10-26 08:05AM	Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics (Business Wire)
Mar-05-26 11:51AM	BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now? (Zacks)
08:44AM	TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? (Zacks)
Mar-04-26 07:00AM	Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America (Business Wire)
Mar-03-26 07:00AM	Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened (Business Wire)
Mar-02-26 02:57AM	Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition (Insider Monkey)
Feb-27-26 04:05PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-26-26 05:00PM	Grail's Stock Dropped 50% on Friday. Investors Still Have High Hopes for the Biotech. (Barrons.com)
07:48AM	Loading…
07:48AM	Guardant Health (GH) Gained from Better-Than-Expected Results (Insider Monkey)
Feb-23-26 06:50PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) -8.42%
01:20PM	Guardant Health acquires MetaSight amid positive 2026 financial outlook (Medical Device Network)
12:00PM	Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know (StockStory)
12:52AM	Guardant buys MetaSight for $59M upfront to acquire blood test tech (MedTech Dive)
Feb-20-26 08:30AM	Guardant Health, Inc. Q4 2025 Earnings Call Summary (Moby)
12:02AM	Guardant Health Inc (GH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-19-26 09:10PM	Guardant Health Q4 Earnings Call Highlights (MarketBeat)
07:00PM	Compared to Estimates, Guardant Health (GH) Q4 Earnings: A Look at Key Metrics (Zacks)
06:00PM	Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:02PM	Guardant Health: Q4 Earnings Snapshot (Associated Press Finance)
04:42PM	Guardant Health (NASDAQ:GH) Surprises With Q4 CY2025 Sales (StockStory)
04:05PM	Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook (Business Wire)
Feb-18-26 05:04PM	Walmart To Report Results, Fresh Off New Highs, A New CEO And $1 Trillion Market Cap (Investor's Business Daily)
Feb-17-26 10:08PM	Earnings To Watch: Guardant Health (GH) Reports Q4 Results Tomorrow (StockStory)
06:48PM	Loading…
06:48PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
10:09AM	What Makes Guardant Health (GH) a Good Healthcare Holding (Insider Monkey)
08:04AM	Palo Alto Earnings Due. How Will Deal Blitz Impact Guidance? (Investor's Business Daily)
Feb-14-26 09:37AM	Boeing Holds In Buy Zone, Leads 5 Stocks To Watch In Short Trading Week (Investor's Business Daily)
Feb-13-26 08:22PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
03:38PM	IPO Stock Of The Week: Health Care Leader BrightSpring Eyes New Buy Point (Investor's Business Daily)
10:20AM	Walmart Stock, Parade Of Gold Leaders Headline Another Busy Earnings Calendar (Investor's Business Daily)
Feb-12-26 02:35PM	Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open (PR Newswire)
10:00AM	Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know (Zacks)
09:10AM	Alnylam Pharmaceuticals (ALNY) Surpasses Q4 Earnings Estimates (Zacks)
Feb-11-26 07:28PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Feb-06-26 07:15AM	Long-Time Bear On Palantir Stock Says More Selling Still To Come (Investor's Business Daily)
Feb-05-26 07:32PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) -7.34%
05:35PM	Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Feb-04-26 05:45PM	Palantir Retreats After Q4 Earnings Pop. Will 'N of 1' Story Work? (Investor's Business Daily) -6.10%
Feb-03-26 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
08:03AM	Stock Market Week: Dow Rally Aces Ninth Month (Investor's Business Daily)
Feb-02-26 04:27PM	Palantir Rebuts Bears With Earnings Beat, Guidance Above Views (Investor's Business Daily)
08:05AM	Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions (Business Wire)
Jan-30-26 05:04AM	Should You Buy Guardant Health Before Feb. 19? (Motley Fool)
Jan-29-26 04:05PM	Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 (Business Wire)
Jan-23-26 07:40AM	Wall Street Has a Positive Opinion on Guardant Health (GH) (Insider Monkey)
Jan-22-26 12:51PM	FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer (Benzinga)
08:05AM	Guardant Health Receives FDA Approval for Guardant360 CDx as Companion Diagnostic for BRAFTOVI (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer (Business Wire)
Jan-20-26 08:54AM	Strong Results and Improved Guidance Lifted Guardant Health (GH) in Q4 (Insider Monkey)
04:58AM	Analysts Turn More Bullish on Guardant Health, Inc. (GH) as 2026 Growth Catalysts Build (Insider Monkey)
Jan-19-26 08:05AM	Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform (Business Wire)
Jan-17-26 05:30AM	Supersize CEO Pay Packages Aren't Paying Off for Shareholders (The Wall Street Journal)
Jan-14-26 10:35PM	Guardant Health (NASDAQ:GH): Strongest Q3 Results from the Testing & Diagnostics Services Group (StockStory)
Jan-11-26 05:00PM	Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results (Business Wire)
01:10AM	Guggenheim Analyst is Bullish on Guardant Health, Inc. (GH) (Insider Monkey)
Jan-10-26 08:00AM	Google, Shopify Lead Big 2025 Winners Near New Buy Points (Investor's Business Daily)
Jan-09-26 02:24PM	Clinical Labs Hope to Head Off Looming Medicare Cuts (Barrons.com)
Jan-08-26 01:30PM	Guardant Health Catapults 234%; Sets Up With Strong Sales Outlook (Investor's Business Daily)
10:31AM	Cathie Wood Dumps $12.7 Million Worth of Meta Stock Amid Ray-Ban Smart Glasses Delay, Ark Loads Up On This Gaming Platform (Benzinga)
08:05AM	Guardant Health's Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families (Business Wire)
Jan-06-26 06:54PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) +10.27%
Dec-31-25 11:33AM	Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside (Insider Monkey)
Dec-29-25 04:05PM	Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
07:59AM	Stock Market Today: Dow Down From Record Highs; Nvidia, Tesla Slide (Live Coverage) (Investor's Business Daily)
Dec-27-25 08:05AM	Palantir, Nvidia Lead 5 Stocks Near Buy Points Heading Into Final Days Of 2025 (Investor's Business Daily)
Dec-26-25 05:23PM	Dow Jones Futures: Tesla, Nvidia Lead 5 Giants In Buy Areas; Market Strong As 2025 Nears End (Investor's Business Daily)
03:41PM	Medical Stocks On The Move In Top Growth List As Health Sector Performance Brightens (Investor's Business Daily)
Dec-22-25 10:19PM	Multiple Analysts Lift Guardant Health, Inc. (GH) Targets on Screening and Data Growth (Insider Monkey)
Dec-16-25 10:41AM	Guardant Health price target raised to $120 from $100 at BofA (TipRanks)
Dec-11-25 08:05AM	Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. (Business Wire)
Dec-09-25 10:19AM	Is Tempus AI Stock a Buy Now or a Hold After a Big 2025 Run? (Zacks)
08:05AM	Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy (Business Wire)
Dec-08-25 10:15AM	Tempus AI: Data Flywheel and MRD Expansion Reshape the Outlook (Zacks)
Dec-05-25 06:42PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) -5.99%
09:41AM	Tempus AI: Revenue Mix and 2026 Growth Outlook Explained (Zacks)
08:05AM	Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium (Business Wire)
Dec-04-25 09:40AM	Is Guardant Health (GH) Stock Outpacing Its Medical Peers This Year? (Zacks)
Dec-03-25 03:27PM	Why Guardant Health (GH) Stock Is Up Today (StockStory)
Nov-24-25 06:40PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) +5.53%
Nov-23-25 11:03PM	Guardant Health (GH): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Nov-20-25 03:45PM	These 15 stocks are still showing momentum - and a market-beating edge (MarketWatch)
01:00PM	The marketing guru who helped turn Khosla Ventures into an AI powerhouse is moving on (TechCrunch)
10:34AM	Stocks to Watch Thursday: Walmart, Nvidia, Exact Sciences, Regeneron (The Wall Street Journal)
09:41AM	Stocks to Watch Thursday: Walmart, Nvidia, Exact Sciences (The Wall Street Journal)
Nov-14-25 07:57AM	TEM Continues to Strengthen Its Genomics Leadership With New Products (Zacks)
Nov-12-25 08:05AM	Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access (Business Wire)
Nov-10-25 08:05AM	Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring (Business Wire)
Nov-07-25 08:00AM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
Nov-06-25 06:35PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:05AM	New Study Validates Guardant Reveal Blood Test's Effectiveness in Monitoring Chemotherapy Response (Business Wire)
07:05AM	Cathie Wood Loads Up Pinterest After Sell-Off -- Dumps Shopify, Roku, and Robinhood (GuruFocus.com)
Nov-05-25 04:05PM	Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients (Business Wire)
12:26PM	Why Guardant Health (GH) Shares Are Sliding Today (StockStory)
02:15AM	Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering (Business Wire)

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saia John G.	Chief Legal Officer	Apr 01 '26	Option Exercise	0.00	11,461	0	68,364	Apr 02 05:24 PM
Monroe Terilyn J.	Chief People Officer	Apr 01 '26	Option Exercise	0.00	8,019	0	29,009	Apr 02 05:23 PM
Kalia Kumud	Chief Information Officer	Apr 01 '26	Option Exercise	0.00	10,044	0	54,341	Apr 02 05:22 PM
Freeman Chris	Chief Commercial Officer	Apr 01 '26	Option Exercise	0.00	11,213	0	64,784	Apr 02 05:22 PM
EAGLE CRAIG	Chief Medical Officer	Apr 01 '26	Option Exercise	0.00	11,400	0	77,780	Apr 02 05:21 PM
Chudova Darya	Chief Technology Officer	Apr 01 '26	Option Exercise	0.00	13,029	0	77,381	Apr 02 05:21 PM
Bell Michael Brian	Chief Financial Officer	Apr 01 '26	Option Exercise	0.00	12,777	0	56,378	Apr 02 05:20 PM
Talasaz AmirAli	Co-Chief Executive Officer	Mar 31 '26	Option Exercise	0.00	2,817	0	2,131,306	Apr 02 05:19 PM
Talasaz AmirAli	Co-Chief Executive Officer	Apr 01 '26	Option Exercise	0.00	33,713	0	2,163,591	Apr 02 05:19 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Mar 31 '26	Option Exercise	0.00	2,817	0	2,097,721	Apr 02 05:19 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Apr 01 '26	Option Exercise	0.00	33,713	0	2,130,006	Apr 02 05:19 PM
Krognes Steve E.	Director	Mar 31 '26	Option Exercise	0.00	155	0	19,208	Apr 01 05:31 PM
MIGNONE ROBERTO	Director	Mar 21 '26	Option Exercise	0.00	264	0	4,487	Mar 23 04:19 PM
Tariq Musa	Director	Mar 18 '26	Sale	88.09	348	30,655	8,394	Mar 19 05:16 PM
Hidalgo Medina Manuel	Director	Mar 17 '26	Option Exercise	0.00	232	0	1,425	Mar 18 05:40 PM
Tariq Musa	Director	Mar 18 '26	Proposed Sale	88.09	348	30,655		Mar 18 04:05 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jan 01 '26	Option Exercise	0.00	38,283	0	2,134,594	Mar 17 09:57 PM
Talasaz AmirAli	Co-Chief Executive Officer	Mar 13 '26	Option Exercise	0.00	26,961	0	2,142,153	Mar 17 09:57 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jan 01 '26	Option Exercise	0.00	38,283	0	2,101,009	Mar 17 09:57 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Mar 13 '26	Option Exercise	0.00	26,961	0	2,108,568	Mar 17 09:57 PM
Tariq Musa	Director	Mar 15 '26	Option Exercise	0.00	249	0	8,742	Mar 17 06:49 PM
Saia John G.	Chief Legal Officer	Mar 15 '26	Option Exercise	0.00	8,811	0	61,525	Mar 17 06:49 PM
Kalia Kumud	Chief Information Officer	Mar 15 '26	Option Exercise	0.00	13,493	0	51,136	Mar 17 06:48 PM
Freeman Chris	Chief Commercial Officer	Mar 15 '26	Option Exercise	0.00	16,828	0	60,698	Mar 17 06:48 PM
EAGLE CRAIG	Chief Medical Officer	Mar 15 '26	Option Exercise	0.00	15,114	0	74,041	Mar 17 06:46 PM
Chudova Darya	Chief Technology Officer	Mar 15 '26	Option Exercise	0.00	10,714	0	70,111	Mar 17 06:46 PM
Bell Michael Brian	Chief Financial Officer	Mar 15 '26	Option Exercise	0.00	13,790	0	54,014	Mar 17 06:46 PM
Bell Michael Brian	Chief Financial Officer	Mar 16 '26	Sale	87.04	3,000	261,111	43,601	Mar 17 06:46 PM
Bell Michael Brian	Officer	Mar 16 '26	Proposed Sale	87.04	3,000	261,111		Mar 16 04:07 PM
Hidalgo Medina Manuel	Director	Mar 06 '26	Option Exercise	32.55	1,000	32,550	2,493	Mar 09 06:38 PM
Hidalgo Medina Manuel	Director	Mar 06 '26	Sale	91.54	1,300	118,997	1,193	Mar 09 06:38 PM
Hidalgo Medina Manuel	Director	Mar 06 '26	Proposed Sale	91.54	1,300	118,997		Mar 06 04:19 PM
Kalia Kumud	Chief Information Officer	Mar 04 '26	Option Exercise	37.48	43,119	1,616,117	77,643	Mar 05 05:44 PM
Kalia Kumud	Chief Information Officer	Mar 04 '26	Sale	95.32	40,000	3,812,661	37,643	Mar 05 05:44 PM
Kalia Kumud	Officer	Mar 04 '26	Proposed Sale	95.32	40,000	3,812,660		Mar 04 04:06 PM
Krognes Steve E.	Director	Feb 28 '26	Option Exercise	0.00	154	0	19,053	Mar 02 04:24 PM
MIGNONE ROBERTO	Director	Feb 21 '26	Option Exercise	0.00	264	0	4,223	Feb 23 05:47 PM
Hidalgo Medina Manuel	Director	Feb 17 '26	Option Exercise	0.00	232	0	1,493	Feb 18 04:27 PM
Tariq Musa	Director	Feb 15 '26	Option Exercise	0.00	250	0	8,493	Feb 17 06:31 PM
Krognes Steve E.	Director	Jan 31 '26	Option Exercise	0.00	154	0	18,899	Feb 02 04:30 PM
Monroe Terilyn J.	Chief People Officer	Jan 21 '26	Sale	114.09	8,571	977,902	20,990	Jan 22 05:45 PM
MIGNONE ROBERTO	Director	Jan 21 '26	Option Exercise	0.00	264	0	3,959	Jan 22 05:44 PM
Monroe Terilyn J.	Officer	Jan 21 '26	Proposed Sale	114.09	8,571	977,902		Jan 21 04:10 PM
Hidalgo Medina Manuel	Director	Jan 17 '26	Option Exercise	0.00	232	0	1,261	Jan 20 04:47 PM
Tariq Musa	Director	Jan 15 '26	Option Exercise	0.00	250	0	8,243	Jan 16 04:39 PM
Monroe Terilyn J.	Chief People Officer	Jan 15 '26	Option Exercise	0.00	17,379	0	38,369	Jan 16 04:39 PM
Monroe Terilyn J.	Chief People Officer	Jan 07 '26	Sale	112.08	10,031	1,124,279	20,990	Jan 09 04:09 PM
Monroe Terilyn J.	Officer	Jan 07 '26	Proposed Sale	112.07	10,031	1,124,200		Jan 07 04:03 PM
Saia John G.	Chief Legal Officer	Jan 01 '26	Option Exercise	0.00	19,046	0	62,703	Jan 05 06:01 PM
Monroe Terilyn J.	Chief People Officer	Jan 01 '26	Option Exercise	0.00	17,555	0	38,545	Jan 05 06:01 PM
Kalia Kumud	Chief Information Officer	Jan 01 '26	Option Exercise	0.00	21,237	0	43,916	Jan 05 06:00 PM
Freeman Chris	Chief Commercial Officer	Jan 01 '26	Option Exercise	0.00	27,237	0	54,032	Jan 05 05:59 PM
EAGLE CRAIG	Chief Medical Officer	Jan 01 '26	Option Exercise	0.00	25,442	0	70,449	Jan 05 05:58 PM
Chudova Darya	Chief Technology Officer	Jan 01 '26	Option Exercise	0.00	22,732	0	29,744	Jan 05 05:57 PM
Bell Michael Brian	Chief Financial Officer	Jan 01 '26	Option Exercise	0.00	23,038	0	52,703	Jan 05 05:57 PM
Talasaz AmirAli	Co-Chief Executive Officer	Dec 31 '25	Option Exercise	0.00	4,815	0	2,002,689	Jan 05 05:56 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jan 01 '26	Option Exercise	0.00	23,997	0	2,024,245	Jan 05 05:56 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Dec 31 '25	Option Exercise	0.00	4,815	0	2,051,958	Jan 05 05:55 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jan 01 '26	Option Exercise	0.00	23,997	0	2,073,514	Jan 05 05:55 PM
Krognes Steve E.	Director	Dec 31 '25	Option Exercise	0.00	154	0	18,745	Jan 05 05:54 PM
MIGNONE ROBERTO	Director	Dec 21 '25	Option Exercise	0.00	264	0	3,695	Dec 23 07:25 PM
Hidalgo Medina Manuel	Director	Dec 17 '25	Option Exercise	0.00	232	0	1,029	Dec 18 06:34 PM
Tariq Musa	Director	Dec 17 '25	Sale	101.46	116	11,769	7,993	Dec 18 06:33 PM
Tariq Musa	Director	Dec 15 '25	Option Exercise	0.00	250	0	8,109	Dec 17 07:21 PM
Saia John G.	Chief Legal Officer	Dec 15 '25	Option Exercise	0.00	1,020	0	44,192	Dec 17 07:20 PM
Kalia Kumud	Chief Information Officer	Dec 15 '25	Option Exercise	0.00	637	0	23,002	Dec 17 07:20 PM
Freeman Chris	Chief Commercial Officer	Dec 15 '25	Option Exercise	0.00	1,402	0	27,389	Dec 17 07:19 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Dec 15 '25	Sale	103.82	90,565	9,402,220	2,047,143	Dec 17 07:18 PM
EAGLE CRAIG	Chief Medical Officer	Dec 15 '25	Option Exercise	0.00	1,402	0	45,718	Dec 17 07:18 PM
Chudova Darya	Chief Technology Officer	Dec 15 '25	Sale	104.04	5,451	567,132	7,012	Dec 17 07:17 PM
Bell Michael Brian	Chief Financial Officer	Dec 15 '25	Option Exercise	0.00	3,272	0	31,324	Dec 17 07:17 PM
Tariq Musa	Director	Dec 17 '25	Proposed Sale	101.46	116	11,769		Dec 17 04:58 PM
Eltoukhy Helmy	Officer	Dec 15 '25	Proposed Sale	103.82	90,565	9,402,223		Dec 15 05:08 PM
Talasaz AmirAli	Co-Chief Executive Officer	Dec 08 '25	Sale	105.05	100,000	10,505,474	168,223	Dec 10 09:33 PM
Kalia Kumud	Chief Information Officer	Dec 08 '25	Sale	104.60	2,000	209,204	22,365	Dec 10 09:32 PM
Hidalgo Medina Manuel	Director	Dec 08 '25	Option Exercise	32.55	1,000	32,550	2,047	Dec 10 09:32 PM
Hidalgo Medina Manuel	Director	Dec 08 '25	Sale	105.00	1,250	131,250	797	Dec 10 09:32 PM
Chudova Darya	Chief Technology Officer	Dec 08 '25	Sale	105.04	13,664	1,435,227	54,480	Dec 10 09:31 PM
Chudova Darya	Chief Technology Officer	Dec 08 '25	Sale	106.00	9,271	982,753	12,463	Dec 10 09:31 PM
Freeman Chris	Chief Commercial Officer	Dec 05 '25	Sale	103.07	31,452	3,241,621	25,987	Dec 08 09:37 PM
Bell Michael Brian	Chief Financial Officer	Dec 05 '25	Option Exercise	30.71	56,287	1,728,787	108,414	Dec 08 09:37 PM
Bell Michael Brian	Chief Financial Officer	Dec 05 '25	Sale	103.14	80,362	8,288,742	28,052	Dec 08 09:37 PM
CLARK IAN T	Director	Dec 05 '25	Option Exercise	35.83	28,611	1,025,156	38,462	Dec 08 09:36 PM
CLARK IAN T	Director	Dec 05 '25	Sale	107.19	28,611	3,066,817	9,851	Dec 08 09:36 PM
Talasaz AmirAli	Officer	Dec 08 '25	Proposed Sale	105.05	100,000	10,505,470		Dec 08 05:50 PM
Chudova Darya	Officer	Dec 08 '25	Proposed Sale	105.43	28,780	3,034,203		Dec 08 04:47 PM
Hidalgo Medina Manuel	Director	Dec 08 '25	Proposed Sale	105.00	1,250	131,250		Dec 08 04:46 PM
Kalia Kumud	Officer	Dec 08 '25	Proposed Sale	104.60	2,000	209,204		Dec 08 04:44 PM
Freeman Chris	Officer	Dec 05 '25	Proposed Sale	103.07	31,452	3,241,621		Dec 05 05:22 PM
CLARK IAN T	Director	Dec 05 '25	Proposed Sale	107.19	28,611	3,066,818		Dec 05 05:21 PM
Bell Michael Brian	Officer	Dec 05 '25	Proposed Sale	103.14	80,362	8,288,741		Dec 05 05:20 PM
Monroe Terilyn J.	Chief People Officer	Dec 01 '25	Option Exercise	22.68	50,000	1,134,050	76,087	Dec 03 09:30 PM
Monroe Terilyn J.	Chief People Officer	Dec 01 '25	Sale	105.97	55,167	5,846,163	20,920	Dec 03 09:30 PM
Krognes Steve E.	Director	Nov 30 '25	Option Exercise	0.00	155	0	18,591	Dec 01 09:41 PM
Monroe Terilyn J.	Officer	Dec 01 '25	Proposed Sale	105.97	55,167	5,846,164		Dec 01 04:56 PM
MIGNONE ROBERTO	Director	Nov 21 '25	Option Exercise	0.00	264	0	3,431	Nov 24 06:21 PM
Tariq Musa	Director	Nov 19 '25	Sale	96.25	116	11,165	7,859	Nov 20 09:27 PM
Tariq Musa	Director	Nov 19 '25	Proposed Sale	96.25	116	11,165		Nov 19 04:01 PM
Hidalgo Medina Manuel	Director	Nov 17 '25	Option Exercise	0.00	232	0	1,047	Nov 18 05:07 PM
Tariq Musa	Director	Nov 15 '25	Option Exercise	0.00	250	0	7,975	Nov 17 05:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GH

Guardant Health Inc

Upgrade your Finviz experience